emerimicins and Pancreatic-Neoplasms

emerimicins has been researched along with Pancreatic-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for emerimicins and Pancreatic-Neoplasms

ArticleYear
Leucinostatin Y: A Peptaibiotic Produced by the Entomoparasitic Fungus Purpureocillium lilacinum 40-H-28.
    Journal of natural products, 2019, 05-24, Volume: 82, Issue:5

    Leucinostatin Y, a new peptaibiotic, was isolated from the culture broth of the entomoparasitic fungus Purpureocillium lilacinum 40-H-28. The planar structure was elucidated by detailed analysis of its NMR and MS/MS data. The absolute configurations of the amino acids were partially determined by an advanced Marfey's method. The biological activities of leucinostatin Y were assessed using human pancreatic cancer cells, revealing the importance of the C-terminus of leucinostatins for preferential cytotoxicity to cancer cells under glucose-deprived conditions and inhibition of mitochondrial function.

    Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Paecilomyces; Pancreatic Neoplasms; Peptaibols

2019